Facebook Instagram X-twitter Linkedin

KPV (10mg)

Table of Contents

  • Quickstart Highlights

KPV (10mg) protocols focus on this tripeptide fragment derived from α-MSH, studied for its potential anti-inflammatory and immune-modulating properties. KPV may help support gut health, skin repair, and systemic inflammation balance without strong immunosuppression. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical daily range: 250–500 mcg once or twice daily (subcutaneous)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support inflammation balance, tissue recovery, and gut/skin health
  • Schedule: Daily subcutaneous injections; once or twice daily depending on need
  • Dose Range: 250–500 mcg per dose
  • Dosing Protocol

Suggested approach for the 10 mg vial format.

  • Start: 250 mcg once daily to assess tolerance
  • Target: 250–500 mcg once or twice daily
  • Frequency: 1–2 times per day (subcutaneous)
  • Vial Duration: One 10 mg vial lasts approximately 10–40 days, depending on dosing
  • Timing: Morning and/or evening; can be taken consistently or split dosing for sustained effect
  • Mechanism of Action

KPV (Lysine-Proline-Valine) is a naturally occurring tripeptide fragment derived from α-melanocyte-stimulating hormone (α-MSH). It is studied for its ability to modulate inflammatory pathways without broadly suppressing immune function.

KPV may act by inhibiting pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, while supporting epithelial barrier integrity in the gut and skin. It is also believed to influence NF-κB signaling pathways, which play a central role in inflammatory responses. These combined effects make it of interest for research into gastrointestinal, dermatological, and systemic inflammatory conditions.

  • Potential Benefits & Side Effects

Observations based on preclinical and early-stage research.

Potential Benefits:

  • May support the reduction of inflammation in the gut and tissues
  • May promote skin and epithelial healing
  • May help maintain intestinal barrier integrity
  • May assist in immune balance without strong suppression

Possible Side Effects:

  • Generally well tolerated in research settings
  • Mild injection-site irritation
  • Occasional fatigue or digestive changes reported
  • Long-term human safety data are limited; it remains investigational